Angiogenic factor AGGF1 acts as a tumor suppressor by modulating p53 post-transcriptional modifications and stability via MDM2
- 15 October 2020
- journal article
- research article
- Published by Elsevier BV in Cancer Letters
- Vol. 497, 28-40
- https://doi.org/10.1016/j.canlet.2020.10.014
Abstract
No abstract availableKeywords
Funding Information
- China National Natural Science Foundation (81630002, 31430047)
- Young Scholar grant (81902860)
- Hubei Province Natural Science Program Innovative Team (2017CFA014)
This publication has 44 references indexed in Scilit:
- AGGF1 is a novel anti-inflammatory factor associated with TNF-α-induced endothelial activationCellular Signalling, 2013
- MOG1 Rescues Defective Trafficking of Na v 1.5 Mutations in Brugada Syndrome and Sick Sinus SyndromeCirculation: Arrhythmia and Electrophysiology, 2013
- Transcriptional activation of the Prox1 gene by HIF‐1α and HIF‐2α in response to hypoxiaFEBS Letters, 2013
- Angiogenic Factor AGGF1 Promotes Therapeutic Angiogenesis in a Mouse Limb Ischemia ModelPLOS ONE, 2012
- A de novo mutation in NKX2.5 associated with atrial septal defects, ventricular noncompaction, syncope and sudden deathClinica Chimica Acta; International Journal of Clinical Chemistry, 2011
- USP10 Regulates p53 Localization and Stability by Deubiquitinating p53Cell, 2010
- Posttranslational Modification of p53: Cooperative Integrators of FunctionCold Spring Harbor Perspectives in Biology, 2009
- Functional Role of Transcriptional Factor TBX5 in Pre-mRNA Splicing and Holt-Oram Syndrome via Association with SC35Online Journal of Public Health Informatics, 2009
- Novel Roles of GATA1 in Regulation of Angiogenic Factor AGGF1 and Endothelial Cell FunctionOnline Journal of Public Health Informatics, 2009
- Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorderNature Genetics, 2005